An existing literature agrees that drug innovation has a significant average effect on extending longevity and improving quality of life. Recognizing the life-saving benefits from the development of new drugs, one of the key decisions faced by the authorities is how to bolster pharmaceutical innovation, and how to bear in mind the potential effects on drug innovation of policies that affect market size, such as policies towards intellectual property rights, procurement mechanisms and competition policy.

Industry’s role in policymaking: Vested interest or critical partner?
Date
Address
Section
Event Location
Event Description
Industry’s role in policymaking: Vested interest or critical partner?
Wednesday, October 19, 2016 from 6:30 PM - 8:30 PM
We have the pleasure of inviting you to a debate on Industry’s role in policymaking. The event will see the launch of our report examining the Role of Industry in EU policymaking.
The notion that some industry sectors have an excessive influence over policymaking has gained currency in recent years and there is increasingly anti-corporate sentiments in some quarters. There is now a major focus on transparency in Brussels and the European Commission will be proposing a new inter-institutional agreement on the Transparency Register. This raises important questions for industry and other stakeholders involved in EU policymaking.
- Is industry a vested interest?
- What are the benefits or costs of industry participation?
- Can there be too much transparency and what effects can this have?
- What trends are we likely to see emerge when it comes to industry involvement and industry access to policymaking?
Join us as we share the outcomes of the research and look at these questions and more. We will announce the panelists at the beginning of October. The discussion will be followed by a cocktail reception.
We hope to see you there.
Related Events
Knowledge4Innovation will be organising the 4th European Innovation Summit from 9 to 10 October 2012 in the European Parliament in Brussels.
COST will be a partner of the fourth European Innovation Summit to be held at the European Parliament in Brussels under the motto 'Building bridges – Creating Synergies'.
SMEs are the backbone of the European economy. Of the approximately 20 million SMEs in Europe, one third is active in the field of commerce.
Monday 5 November 2012 (day 1)
15:00-16:30: European Parliament Briefing (optional): Enterprise Forum members will have the opportunity to attend a briefing on how the European Parliament works. Paul-Henri Spaak Building, Rue Wiertz, B-1047 Brussels
Securing Europe‘s Raw Material Supply in the Context of Resource Efficiency and EU Industry Policy
There is no energy- and resource efficiency, no climate protection, no future technologies for our modern
world without the use of non-ferrous metals.
UEAPME and ACCA invite you to
Unleashing entrepreneurial potential in Europe
22 January 2013
UEAPME conference room , rue Jacques de Lalaing , 4, 1040 Brussels
Dinner Debate: How Can Networking in Science and Technology Help SMEs Meet the Innovation Union Goals?
Venue: European Parliament
Date: 29 January 2013 19:30-22:00
Brussels hosts more than 100.000 persons working in EU affairs. Less than 50% are based in the EU institutions, the other 50.000 persons have a job in industry federations, consultancies, media, corporate, nonprofit organizations, think tanks or region and city representations.
Bulgarian investment forum
Wed, 20 March, 15:30
Crowne Plaza Hotel, Rue Gineste 3, B-1210, Brussels
‘Restarting the SME credit market in Europe: what role for securitisation and the capital markets?’’
‘Restarting the SME credit market in Europe:
what role for securitisation and the capital markets?’’
Hosted by Othmar Karas, MEP
On April 10th, educators, policy makers and industry leaders will gather to discuss how to empower youth and close the skills gap to boost competitiveness and innovation across Europe.
Pages
Events of the week
Jobs
EURACTIV News
- Legal affairs committee seeks easier residence permits for non-EU workers
- Delay of EU pharma reform faces criticism from MEPs, stakeholders
- Carbon farming law only ‘first step’ in negative emissions push
- ‘Carbon neutral’ food claims challenged under new Commission rules
- Over 200,000 illegal pushbacks at EU external borders, says report